Samuel Z Goldhaber Selected Research

Enoxaparin (Lovenox)

1/2021	Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
2/2020	Extended prophylaxis of venous thromboembolism with betrixaban in acutely ill medical patients with and without cancer: insights from the APEX trial.
1/2020	Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.
12/2019	Net-clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or more.
4/2019	Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial.
1/2019	Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy.
1/2018	Association of D-dimer Levels with Clinical Event Rates and the Efficacy of Betrixaban versus Enoxaparin in the APEX Trial.
1/2018	Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy.
12/2017	Thrombus Burden of Deep Vein Thrombosis and Its Association with Thromboprophylaxis and D-Dimer Measurement: Insights from the APEX Trial.
11/2017	Competing risk analysis in a large cardiovascular clinical trial: An APEX substudy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Samuel Z Goldhaber Research Topics

Disease

71	Venous Thromboembolism 08/2022 - 12/2002
65	Hemorrhage 01/2022 - 04/2003
60	Pulmonary Embolism 02/2022 - 03/2002
34	Venous Thrombosis (Deep-Vein Thrombosis) 02/2022 - 12/2002
31	Stroke (Strokes) 01/2022 - 04/2003
31	Atrial Fibrillation 01/2022 - 08/2005
27	Thrombosis (Thrombus) 01/2022 - 06/2009
19	Neoplasms (Cancer) 01/2022 - 12/2002
11	COVID-19 01/2022 - 01/2020
10	Embolism (Embolus) 01/2022 - 05/2005
10	Heart Failure 02/2021 - 04/2003
7	Hypertension (High Blood Pressure) 02/2021 - 04/2003
7	Right Ventricular Dysfunction 10/2015 - 03/2002
6	Hypotension (Low Blood Pressure) 01/2022 - 06/2003
6	Myocardial Infarction 01/2019 - 10/2002
6	Thrombocytopenia (Thrombopenia) 01/2018 - 09/2004
6	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 06/2007
5	Vascular Diseases (Vascular Disease) 01/2022 - 01/2017
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 07/2005
4	Diabetes Mellitus 02/2021 - 01/2006
4	Thromboembolism 02/2021 - 09/2013
4	Critical Illness (Critically Ill) 01/2021 - 09/2017
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 01/2011
4	Postthrombotic Syndrome 10/2019 - 02/2012
4	Drug-Related Side Effects and Adverse Reactions 01/2012 - 11/2007
3	Acute Coronary Syndrome 01/2020 - 02/2013
3	Renal Insufficiency (Renal Failure) 01/2019 - 11/2016
3	Atherosclerosis 01/2019 - 10/2010
3	Chronic Renal Insufficiency 01/2019 - 07/2012
3	Type 2 Diabetes Mellitus (MODY) 01/2019 - 04/2003
3	Coronary Disease (Coronary Heart Disease) 01/2019 - 11/2009
3	Obesity 09/2015 - 02/2005
3	Diabetic Nephropathies (Diabetic Nephropathy) 07/2005 - 04/2003
2	Peripheral Arterial Disease 01/2022 - 12/2011
2	Dyslipidemias (Dyslipidemia) 10/2021 - 05/2021
2	Body Weight (Weight, Body) 01/2021 - 06/2004
2	Wounds and Injuries (Trauma) 01/2021 - 09/2017
2	Multiple Myeloma 01/2020 - 01/2019
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 02/2019 - 08/2015
2	Ischemic Stroke 02/2019 - 01/2017
2	Inflammation (Inflammations) 01/2019 - 01/2019
2	Thrombophilia 12/2016 - 05/2002
2	Chest Pain (Chest Pains) 02/2016 - 02/2016

Drug/Important Bio-Agent (IBA)

58	AnticoagulantsIBA 08/2022 - 07/2004
40	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 04/2003
23	Enoxaparin (Lovenox)FDA LinkGeneric 01/2021 - 12/2002
19	betrixabanIBA 07/2021 - 03/2014
17	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 12/2002
15	Vitamin K FDA Link 01/2022 - 07/2007
13	Dabigatran FDA Link 01/2022 - 12/2009
12	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021 - 07/2004
12	fibrin fragment D (D-dimer)IBA 01/2019 - 08/2002
9	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2021 - 01/2006
9	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2002
8	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 04/2006
7	apixabanIBA 01/2022 - 12/2011
7	RivaroxabanIBA 01/2022 - 07/2007
6	EnzymesIBA 12/2020 - 08/2002
5	TroponinIBA 01/2022 - 10/2002
4	Pharmaceutical PreparationsIBA 01/2022 - 09/2004
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021 - 12/2020
4	Factor Xa InhibitorsIBA 02/2021 - 07/2007
4	edoxabanIBA 01/2021 - 01/2015
4	C-Reactive ProteinIBA 01/2019 - 10/2010
4	Fondaparinux (Arixtra)FDA Link 04/2013 - 12/2007
4	Irbesartan FDA LinkGeneric 05/2010 - 04/2003
3	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2021 - 07/2020
3	CreatinineIBA 01/2021 - 04/2003
3	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2017 - 05/2003
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 04/2003
3	Dalteparin (Dalteparin Sodium)FDA Link 04/2013 - 08/2004
3	Thrombin FDA Link 12/2012 - 04/2006
3	ImmunosorbentsIBA 01/2012 - 08/2002
2	LipidsIBA 10/2021 - 05/2021
2	dalcetrapibIBA 10/2021 - 05/2021
2	Triglycerides (Triacylglycerol)IBA 10/2021 - 05/2021
2	Niacin (Nicotinic Acid)FDA LinkGeneric 10/2021 - 05/2021
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2021 - 05/2021
2	Fibric Acids (Fibrates)IBA 10/2021 - 05/2021
2	HDL CholesterolIBA 10/2021 - 05/2021
2	AntithrombinsIBA 02/2021 - 03/2015
2	Immunomodulating AgentsIBA 01/2020 - 01/2019
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019 - 03/2017
2	cupric sulfide (CuS)IBA 12/2018 - 01/2018

Therapy/Procedure

56	Therapeutics 11/2022 - 03/2002
24	Catheters 01/2022 - 10/2006
10	Embolectomy 01/2020 - 03/2002
6	Vena Cava Filters (Inferior Vena Cava Filter) 01/2019 - 06/2005
6	Thrombolytic Therapy 01/2017 - 08/2005
5	Central Venous Catheters 08/2019 - 09/2004
5	Compression Stockings 04/2013 - 12/2002
4	Contraindications 09/2017 - 05/2005
4	Radiotherapy 01/2017 - 11/2005
3	Orthopedic Procedures 01/2022 - 12/2007
3	Extracorporeal Membrane Oxygenation 01/2022 - 12/2020
3	Critical Care (Surgical Intensive Care) 01/2022 - 01/2017
3	Length of Stay 01/2020 - 01/2016
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2011 - 06/2004
2	Drug Tapering 01/2022 - 11/2016
2	Patient Readmission 01/2020 - 01/2018